Conclusion: Among critically ill adults with septic shock, based on low-certainty evidence, MB may reduce short-term mortality, duration of vasopressors, and hospital length of stay, with no evidence of increased adverse events. Rigorous randomized trials evaluating the efficacy of MB in septic shock are needed.
PubMed 38904978 ↗Methylene Blue
The short answer. More people than not who report on Methylene Blue say it helped (64% of 37). It is most often used for focus: 100% of 23 reports say that improved. It is well studied — 131 meta-analyses on PubMed.
From 132 mentions in total — the rest didn't say how it went and aren't counted.
What Methylene Blue does, according to users
Of the people who reported each effect, the share who said it got better.
4 more with fewer than 3 reports
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 131 meta-analyses on PubMed ↗ · 382 randomized trials ↗
Conclusion: The evidence supporting the use of hydroxocobalamin for shock is limited to anecdotal reports and a few cohort studies. Hydroxocobalamin appears to positively affect hemodynamics in shock, albeit similar to methylene blue.
PubMed 37147207 ↗Conclusion: This meta-analysis demonstrated that methylene blue administration was associated with an increased in mean arterial pressure and PaO2/FiO2 ratio, along with a reduction in mortality rates, serum lactate levels, and length of hospital stay. However, substantial degree of heterogeneity and inadequate number of studies with low level of evidence warrant future adequately powered RCTs to affirm our results.
PubMed 39615751 ↗Conclusion: This meta-analysis showed that MB reverses vasodilation in critically ill and perioperative patients and might improve survival. Further adequately powered randomized trials are needed to confirm these findings.
PubMed 37880041 ↗345 human trials on ClinicalTrials.gov test Methylene Blue — 182 completed, 36 recruiting now. See all on ClinicalTrials.gov ↗
- Antimicrobial Photodynamic Therapy in the Endodontic Treatment of Anterior Primary Teeth With Pulp Necrosis · Dental Pulp Necroses, Tooth, Nonvital · 2026
- Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections - Canada · Surgical Site Infections, Infections · 2026
- Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections · Surgical Site Infections, Surgical Wound Infection · 2026
What government agencies say
Official records from US, Canadian and EU regulators, each linked to its source.
NIH has funded 7 research projects with Methylene Blue in the title, $4,425,142 in total (1994–2018). NIH RePORTER ↗
Dosage people report
As stated by users — not a recommendation. Follow the label or your doctor.
Reported side effects
How often each side effect came up across all reports.
What users say
First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.
“Seems to be doing something. My Dual N back scores are up. My social anxiety also seems to be getting better. I am taking 60mcg 3x daily approximately every 5 hours.”
“Just 10mg and it's like my brain switches back on. I feel clear, focused, motivated...Brain fog is gone. Inflammation in my body is practically gone...I definitely don't feel more physically energized.”
“First thing I noticed was mental clarity, not jittery like caffeine, just cleaner focus.”
“I have noted really good benefits since day 1. I have been breathing much better...mental clarity. I cannot name any notably bad reactions.”
Methylene Blue compared
Other options for focus
Sources
- User reports: 132 mentions in public discussions, quoted with a link to each discussion (e.g. this thread ↗).
- PubMed (US National Library of Medicine, NIH): meta-analyses ↗ · randomized trials ↗
- ClinicalTrials.gov (NIH): registered trials ↗
- NIH RePORTER ↗
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate